M. Hartmann

A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes

E. Proschak, J. Imig, René Blöcher, 2018, Diabetologia.

Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase

Sandra K. Wittmann, D. Steinhilber, E. Proschak, 2016, Molecules.

N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators.

Sandra K. Wittmann, D. Steinhilber, B. Brüne, 2016, Journal of medicinal chemistry.

Nonacidic Farnesoid X Receptor Modulators.

Ewgenij Proschak, Manfred Schubert-Zsilavecz, Daniel Merk, 2017, Journal of medicinal chemistry.

Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase.

J. Leppänen, E. Proschak, S. Auriola, 2018, Bioorganic chemistry.

Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases.

Sandra K. Wittmann, D. Steinhilber, Franca-Maria Klingler, 2017, ACS infectious diseases.

Demonstrating Ligandability of the LC3A and LC3B Adapter Interface.

S. Knapp, H. Stark, V. Dötsch, 2021, Journal of medicinal chemistry.

Dual Soluble Epoxide Hydrolase Inhibitor/PPAR-γ Agonist Attenuates Renal Fibrosis.

E. Proschak, J. Imig, Marla A. Chesnik, 2020, Prostaglandins & other lipid mediators.

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast

E. Proschak, D. Merk, Pascal Heitel, 2019, ChemMedChem.